Cancer gene therapy-mediated by oncolytic adenoviruses (Ads) encoding immunostimulatory interleukin-12 (IL-12) gene, or pro-apoptotic tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene, have been recently emerged as a novel strategy in cancer therapy. This evidence concerns the gene TNFSF10 and cancer.